This collection investigates how European Union law navigates the complex intersection of innovation, safety, and ethical governance regarding emerging health technologies. Edited by Mark L. Flear, the text compiles contributions from legal scholars and regulatory experts to examine the tension between fostering medical advancement and maintaining rigorous public oversight. The work argues that existing regulatory frameworks must adapt to address the specific challenges posed by rapid scientific development, including issues of risk management, human rights, and market access.

Experts identify this collection as a significant contribution to the study of European health governance and regulatory theory. Readers frequently note the academic density of the prose, making it a suitable resource for legal scholars and policy researchers interested in the intersection of science and law.